- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03488407
Evaluation of Feasibility of Radial Access for Primary Angioplasty and to Assess it in High Risk Subgroups
A Prospective Study to Evaluate Feasibility of Routine Use of Radial Access for Primary Angioplasty and to Assess it in Subgroups With Unfavorable Characteristics
Primary percutaneous coronary intervention is the preferred treatment for patients with ST-segment acute coronary syndrome. The radial access is an established approach, associated with a reduction in vascular access related complications after primary percutaneous coronary interventions. The purpose of this study is to examine the baseline characteristics, risk factors, procedural parameters and complications in patients with STEMI taken for primary angioplasty by radial access.
Data of all patients with acute STEMI with primary PCI through radial access is to be evaluated for baseline characteristics and procedural parameters and complications. Patients in the prospective study are followed up till discharge and any in-hospital complication noted.
This was a prospective, observational and descriptive study. Three hundred fifteen consecutive patients with an ST-segment elevation acute myocardial infarction (STEMI) treated with primary angioplasty by radial access, admitted between March 2016 and Feb 2017 were analyzed for their baseline characteristics, risk factors, and procedural parameters, complications and outcomes. High risk sub-groups analysis was also done. High risk groups includes patients with age >75yrs, cardiogenic shock, severe LV systolic dysfunction, acute left ventricular failure, high degree AV block, right ventricular infarction and low BMI. The study is conducted among patients with acute STEMI, considered for primary PCI through radial artery access at operator discretion.
This study analyzed the baseline characteristics of patients which includes clinical history, clinical examination, ECG, 2D ECHO, coronary angiogram to evaluate cardiovascular risk factors.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- All patients presenting with STEMI and being considered for primary PCI through radial access between March 2016 and Feb 2017.
Exclusion Criteria:
- Patients with ACS other than STEMI
- All primary PCI in STEMI through femoral access.
- All radial elective PCI.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Evaluation of radial angioplasty success in whole cohort.
Time Frame: one year
|
Angioplasty success rate (by TIMI flow grade)
|
one year
|
Evaluation of in-hospital complication.
Time Frame: One year
|
Rate of local complications
|
One year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
High risk v/s non-high risk subgroup analysis
Time Frame: one year
|
Non- inferiority of radial angioplasty for high risk group were assessed.
|
one year
|
Collaborators and Investigators
Investigators
- Principal Investigator: Rajesh Sharma, MD, Jubilee Mission Medical College & Research Institute
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2/16/IEC/JMMC&RI
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Primary Angioplasty
-
Ralf Degenhardt, PhDB. Braun Melsungen AGCompleted
-
University Hospital, ToulouseCompletedAngioplastySpain, Russian Federation, Italy, France, Austria, Germany, Greece, Poland
-
University of PatrasCompleted
-
Weill Medical College of Cornell UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedAngioplasty PatientsUnited States
-
Weill Medical College of Cornell UniversityCompletedAngioplasty PatientsUnited States
-
French Cardiology SocietyCompletedIntracoronary AngioplastyFrance
-
Association de Musicothérapie Applications et Recherches...American Hospital of ParisCompleted
-
Indus Hospital and Health NetworkCompletedAngioplasty | CoronaryPakistan
-
Weill Medical College of Cornell UniversityCompletedAngioplasty PatientsUnited States
-
University Hospital, BordeauxCompletedCoronary Angiography | AngioplastyFrance